Cargando…
Identification of antiviral antihistamines for COVID-19 repurposing
There is an urgent need to identify therapies that prevent SARS-CoV-2 infection and improve the outcome of COVID-19 patients. Although repurposed drugs with favorable safety profiles could have significant benefit, widely available prevention or treatment options for COVID-19 have yet to be identifi...
Autores principales: | Reznikov, Leah R., Norris, Michael H., Vashisht, Rohit, Bluhm, Andrew P., Li, Danmeng, Liao, Yan-Shin J., Brown, Ashley, Butte, Atul J., Ostrov, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713548/ https://www.ncbi.nlm.nih.gov/pubmed/33309272 http://dx.doi.org/10.1016/j.bbrc.2020.11.095 |
Ejemplares similares
-
Repurposing Cationic Amphiphilic Antihistamines for Cancer Treatment
por: Ellegaard, Anne-Marie, et al.
Publicado: (2016) -
Repurposing the Antihistamine Terfenadine for Antimicrobial
Activity against Staphylococcus aureus
por: Perlmutter, Jessamyn I., et al.
Publicado: (2014) -
From Genes to Geography, from Cells to Community, from Biomolecules to Behaviors: The Importance of Social Determinants of Health
por: Davidson, Jaysón, et al.
Publicado: (2022) -
Literature-Based Discovery Predicts Antihistamines Are a Promising Repurposed Adjuvant Therapy for Parkinson’s Disease
por: Tandra, Gabriella, et al.
Publicado: (2023) -
A review of antihistamines used during pregnancy
por: Kar, Sumit, et al.
Publicado: (2012)